1. Home
  2. EVTC vs COLL Comparison

EVTC vs COLL Comparison

Compare EVTC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$30.20

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$46.06

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
COLL
Founded
1988
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
EVTC
COLL
Price
$30.20
$46.06
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$35.80
$51.17
AVG Volume (30 Days)
379.5K
514.4K
Earning Date
02-25-2026
02-26-2026
Dividend Yield
0.67%
N/A
EPS Growth
76.90
N/A
EPS
2.26
1.63
Revenue
$903,381,000.00
$757,067,000.00
Revenue This Year
$11.45
$26.17
Revenue Next Year
$5.64
$3.65
P/E Ratio
$13.26
$28.25
Revenue Growth
9.67
26.34
52 Week Low
$26.72
$23.23
52 Week High
$38.56
$50.79

Technical Indicators

Market Signals
Indicator
EVTC
COLL
Relative Strength Index (RSI) 55.16 48.05
Support Level $28.65 $43.62
Resistance Level $30.28 $46.94
Average True Range (ATR) 0.77 1.84
MACD -0.02 -0.19
Stochastic Oscillator 77.04 50.16

Price Performance

Historical Comparison
EVTC
COLL

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: